ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-28 Cr | ₹46 Cr | ₹11 Cr | ₹40 Cr | ₹37 Cr |
What is the latest Cash Flow from Operating Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-28 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹37 Cr |
How is Cash Flow from Operating Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-28 Cr | Negative | |
| Mar2024 | ₹46 Cr | 332.73 | |
| Mar2023 | ₹11 Cr | -73.98 | |
| Mar2022 | ₹40 Cr | 10.38 | |
| Mar2021 | ₹37 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹399.6 Cr | -0.5% | 0.5% | -21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0.5% |
0.5% |
-21.4% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses